0001213900-17-010833.txt : 20171023 0001213900-17-010833.hdr.sgml : 20171023 20171023163833 ACCESSION NUMBER: 0001213900-17-010833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171020 FILED AS OF DATE: 20171023 DATE AS OF CHANGE: 20171023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Paul Edward CENTRAL INDEX KEY: 0001658544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55347 FILM NUMBER: 171149274 MAIL ADDRESS: STREET 1: 300 EAST 56TH STREET, APT 19E CITY: NEW YORK, STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RELMADA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001553643 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455401931 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3853 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: CAMP NINE, INC. DATE OF NAME CHANGE: 20120706 4 1 f4101917kelly_relmada.xml OWNERSHIP DOCUMENT X0306 4 2017-10-20 0 0001553643 RELMADA THERAPEUTICS, INC. RLMD 0001658544 Kelly Paul Edward C/O RELMADA THERAPEUTICS, INC. 750 THIRD AVENUE, 9TH FLOOR NEW YORK, NY 10016 1 0 0 0 Options to purchase common stock 0.81 2017-10-20 4 A 0 450000 0.81 A 2027-10-20 Common Stock 450000 450000 D Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant. /s/ Paul E. Kelly 2017-10-23